Free press releases distribution network?

Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



George Weinstock, Washington University to Keynote GTC’s NGS Meeting on June 19-21 in San Francisco - George Weinstock, Leader of the Human Microbiome Project and Professor of Genetics and Molecular Microbiology at Washington University at St. Louis, Will Give a Keynote Presentation at GTC’s 3rd Next Generation Sequencing Conference - GTCbio.com
George Weinstock, Washington University to Keynote GTC’s NGS Meeting on June 19-21 in San Francisco

 

PRZOOM - /newswire/ - Monrovia, CA, United States, 2013/02/21 - George Weinstock, Leader of the Human Microbiome Project and Professor of Genetics and Molecular Microbiology at Washington University at St. Louis, Will Give a Keynote Presentation at GTC’s 3rd Next Generation Sequencing Conference - GTCbio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

George Weinstock, professor at Washington University at St. Louis, will give a keynote presentation on “The Microbiome, Infectious Diseases, and NGS” at GTC’s 3rd Next Generation Sequencing Conference on June 19 21, in San Francisco, CA

The last few years have seen a revolution in microbiology due to NGS. The Human Microbiome Project and metagenomic analysis, previously stymied by the requirement for large-scale sequencing of complex microbial communities, was unblocked by applications of 454 and Illumina platforms in 16S rDNA and shotgun sequencing, respectively. These are also playing a major role in virome analysis, revealing new patterns of virus infection in humans. Complementing this analysis of microbial communities is the sequencing of individual species in pure culture. This has been applied to outbreak strains, population genetics, sub-species analysis, and other applications and is transforming our knowledge of microbes. Examples of all of these applications will be presented as well as speculation on the trajectory for the future.

Dr. George Weinstock is currently Professor of Genetics and Professor of Molecular Microbiology at Washington University at St. Louis. He was one of the leaders of the Human Genome Project and also the first personal genome project, sequencing Dr. James Watson’s genome using next-generation sequencing technology. He is now a leader of the Human Microbiome Project, studying the collection of microbes that colonize the human body.

The 3rd Next Generation Sequencing Conference will provide a forum for industry, academic and government leaders in the field to present on the current and future applications of the technology as well as share strategies, best practices and protocols on the usage of the tool. Hot topics that will be covered include clinical diagnostics development, the microbiome and infectious disease applications, bioinformatics and methods of data analysis, nanopore sequencing and other future sequencing technologies on the horizon.

This conference is part of the Nucleic Acid Summit and will run parallel with the 4th RNAi Research & Therapeutics Conference.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


George Weinstock, Washington University to Keynote GTC’s NGS Meeting on June 19-21 in San Francisco

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  MagLar, Inc.

Visit  BizJobs.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today